Trial description:
Randomized, Double-Blind Phase 2/3 Study in Subjects with Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression to Assess ADI-PEG 20 with Pemetrexed and Cisplatin
Contact name:
Dr David Gilligan
Trial start date:
Monday, March 5, 2018
Trial end date:
Saturday, January 25, 2020
Trial tumour type:
Lung
Show on Radiotherapy:
No